BPC-157 (Body Protection Compound-157) is widely researched for its role in supporting cellular repair pathways, vascular integrity, and soft tissue research models
Pharmacologically, BPC-157 exhibits rapid absorption following administration, with studies in rats and dogs indicating a half-life of less than 30 minutes after intravenous or intramuscular delivery
developmental and nutritional disorders in young animals due to rearing disease, and (secondary) ketosis in cows)
Please complete the verification below to continue.
By purchasing, you confirm that you are over 18 years of age , that you understand the products are for research only, and that you accept full responsibility for compliance with all relevant laws and regulations.
Summary: Both methylcobalamin and cyanocobalamin effectively treat B12 deficiency, with cyanocobalamin being more stable and cost-effective whilst methylcobalamin is bioactive without requiring conversion